Rodman & Renshaw Starts Eyegate Pharmaceuticals (EYEG) at Buy

February 1, 2016 7:32 AM EST
Get Alerts EYEG Hot Sheet
Price: $34.56 +0.17%

Rating Summary:
    4 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 6 | Down: 7 | New: 77
Join SI Premium – FREE

Rodman & Renshaw initiated coverage on Eyegate Pharmaceuticals (NASDAQ: EYEG) with a Buy rating and a price target of $10.00.

For an analyst ratings summary and ratings history on Eyegate Pharmaceuticals click here. For more ratings news on Eyegate Pharmaceuticals click here.

Shares of Eyegate Pharmaceuticals closed at $1.70 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Rodman & Renshaw